{"id":831248,"date":"2022-11-01T18:01:17","date_gmt":"2022-11-01T17:01:17","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/"},"modified":"2022-11-01T18:01:17","modified_gmt":"2022-11-01T17:01:17","slug":"orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/","title":{"rendered":"OrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders"},"content":{"rendered":"-- Company advances two clinical and two preclinical programs targeting fundamental aspects of energy metabolism --\n\nPALO ALTO, Calif.--(BUSINESS WIRE)--#TLM22--OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for severe metabolic disorders, today announced four development programs that target fundamental pathways of cellular energetics. OrsoBio is led by Chief Executive Officer, Mani Subramanian, MD, PhD, and Chief Medical Officer, Rob Myers, MD, who previously led the Liver Diseases Therapeutic Area at Gilead Sciences. The company was incubated by leading Bay Area-based venture capital firm Samsara BioCapital and builds upon the scientific work of Drs. Gerald Shulman (Yale University), Johan Auwerx (\u00c9cole
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

— Company advances two clinical and two preclinical programs targeting fundamental aspects of energy metabolism — PALO ALTO, Calif.–(BUSINESS WIRE)–#TLM22–OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for severe metabolic disorders, today announced four development programs that target fundamental pathways of cellular energetics. OrsoBio is led by Chief Executive Officer, Mani Subramanian, MD, PhD, and […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-831248","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nOrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders - BeBeez\" \/>\n<meta property=\"og:description\" content=\"-- Company advances two clinical and two preclinical programs targeting fundamental aspects of energy metabolism -- PALO ALTO, Calif.--(BUSINESS WIRE)--#TLM22--OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for severe metabolic disorders, today announced four development programs that target fundamental pathways of cellular energetics. OrsoBio is led by Chief Executive Officer, Mani Subramanian, MD, PhD, and […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-01T17:01:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"OrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders\",\"datePublished\":\"2022-11-01T17:01:17+00:00\",\"dateModified\":\"2022-11-01T17:01:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/\"},\"wordCount\":716,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/\",\"name\":\"OrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-11-01T17:01:17+00:00\",\"dateModified\":\"2022-11-01T17:01:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/","og_locale":"en_US","og_type":"article","og_title":"OrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders - BeBeez","og_description":"-- Company advances two clinical and two preclinical programs targeting fundamental aspects of energy metabolism -- PALO ALTO, Calif.--(BUSINESS WIRE)--#TLM22--OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for severe metabolic disorders, today announced four development programs that target fundamental pathways of cellular energetics. OrsoBio is led by Chief Executive Officer, Mani Subramanian, MD, PhD, and […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/","og_site_name":"BeBeez","article_published_time":"2022-11-01T17:01:17+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/"},"author":{"name":"","@id":""},"headline":"OrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders","datePublished":"2022-11-01T17:01:17+00:00","dateModified":"2022-11-01T17:01:17+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/"},"wordCount":716,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/","name":"OrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-11-01T17:01:17+00:00","dateModified":"2022-11-01T17:01:17+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"OrsoBio Launches to Develop Novel Therapies for Patients with Severe Metabolic Disorders"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/831248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=831248"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/831248\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=831248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=831248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=831248"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=831248"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=831248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}